Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid

    Detection of peritoneal dissemination (PD) in gastric cancer (GC) patients remains challenging. The feasibility of tumor-guided cell-free DNA (cfDNA) detection in prospectively collected peritoneal fluid (asci...

    Karen van der Sluis, Johanna W. van Sandick, Marieke A. Vollebergh in Oncogene (2024)

  2. Article

    Open Access

    Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients

    Colibactin, a genotoxin produced by polyketide synthase harboring (pks+) bacteria, induces double-strand breaks and chromosome aberrations. Consequently, enrichment of pks+Escherichia coli in colorectal cancer an...

    Diantha Terlouw, Arnoud Boot, Quinten R. Ducarmon, Sam Nooij, Manon Suerink in BMC Cancer (2024)

  3. Article

    Open Access

    Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas

    Previous studies in patients with mature B-cell lymphomas (MBCL) have shown that pathogenic TP53 aberrations are associated with inferior chemotherapeutic efficacy and survival outcomes. In solid malignancies, p5...

    Lorraine M. de Haan, Ruben A. L. de Groen, Fleur A. de Groot in Virchows Archiv (2023)

  4. Article

    Open Access

    Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development

    Mutations in Bone Morphogenetic Protein (BMP) Receptor (BMPR)1A and SMAD4 are detected in 50% of juvenile polyposis syndrome (JPS) patients, who develop stroma-rich hamartomatous polyps. The established role of s...

    Sarah Ouahoud, Barbara Florien Westendorp in Journal of Gastroenterology (2023)

  5. No Access

    Article

    Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors

    Non-seminoma testicular cancer survivors (TCS) have an increased risk of develo** colorectal cancer (CRC) when they have been treated with platinum-based chemotherapy. Previously we demonstrated that among H...

    Berbel L. M. Ykema, Emilie C. H. Breekveldt, Beatriz Carvalho in British Journal of Cancer (2022)

  6. Article

    Open Access

    Author Correction: Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

    Jiri Jungwirth, Marketa Urbanova, Arnoud Boot, Petr Hosek in Scientific Reports (2022)

  7. Article

    Open Access

    Author Correction: Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

    Jiri Jungwirth, Marketa Urbanova, Arnoud Boot, Petr Hosek in Scientific Reports (2022)

  8. Article

    Open Access

    Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas

    Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) and primary cutaneous follicle center lymphoma with a diffuse population of large cells (PCFCL-LC) are both primary cutaneous B-cell lymph...

    Anne M. R. Schrader, Ruben A. L. de Groen, Rein Willemze in Virchows Archiv (2022)

  9. Article

    Open Access

    Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

    A large proportion of colorectal carcinomas (CRC) evolve from colorectal adenomas. However, not all individuals with colonic adenomas have a risk of CRC substantially higher than those of the general populatio...

    Jiri Jungwirth, Marketa Urbanova, Arnoud Boot, Petr Hosek in Scientific Reports (2022)

  10. No Access

    Article

    Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4

    Long-term use of statins is associated with a small reduced risk of colorectal cancer but their mechanism of action is not well understood. While they are generally believed to act on KRAS, we have previously ...

    Sarah Ouahoud, Rutger J. Jacobs, Ludmilla L. Kodach in British Journal of Cancer (2022)

  11. Article

    Open Access

    Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients

    In addition to classic germline APC gene variants, APC mosaicism and deep intronic germline APC variants have also been reported to be causes of adenomatous polyposis. In this study, we investigated 80 unexplaine...

    Fadwa A. Elsayed, Carli M. J. Tops, Maartje Nielsen, Hans Morreau in Familial Cancer (2022)

  12. Article

    Open Access

    Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing

    In routine diagnostic pathology, cancer biopsies are preserved by formalin-fixed, paraffin-embedding (FFPE) procedures for examination of (intra-) cellular morphology. Such procedures inadvertently induce DNA ...

    Amin Allahyar, Mark Pieterse, Joost Swennenhuis in Nature Communications (2021)

  13. Article

    Open Access

    “The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor

    Winand N. M. Dinjens, Marjolijn J. L. Ligtenberg, Tom van Wezel in Virchows Archiv (2021)

  14. Article

    Open Access

    Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing

    Acute myeloid leukemia (AML) is caused by genetic aberrations that also govern the prognosis of patients and guide risk-adapted and targeted therapy. Genetic aberrations in AML are structurally diverse and cur...

    Wibowo Arindrarto, Daniel M. Borràs, Ruben A. L. de Groen in Leukemia (2021)

  15. No Access

    Article

    Targeted next generation sequencing screening of Lynch syndrome in Tunisian population

    A high colorectal cancer (CRC) incidence is observed in Tunisia, with a relatively high proportion of patients develo** CRC before the age of 40. While this suggests a genetic susceptibility, only a few Tuni...

    Rihab Ben Sghaier, Anne Maria Lucia Jansen, Ahlem Bdioui, Tom Van Wezel in Familial Cancer (2019)

  16. Article

    Open Access

    Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics

    Next-generation sequencing (NGS) panel analysis on DNA from formalin-fixed paraffin-embedded (FFPE) tissue is increasingly used to also identify actionable copy number gains (gene amplifications) in addition t...

    Astrid Eijkelenboom, Bastiaan B. J. Tops, Anke van den Berg in Virchows Archiv (2019)

  17. Article

    Open Access

    SNP association study in PMS2-associated Lynch syndrome

    Lynch syndrome (LS) patients are at high risk of develo** colorectal cancer (CRC). Phenotypic variability might in part be explained by common susceptibility loci identified in Genome Wide Association Studie...

    Sanne W. ten Broeke, Fadwa A. Elsayed, Lisa Pagan in Familial Cancer (2018)

  18. Article

    Open Access

    Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer

    Patients synchronously or metachronously presenting with ovarian and colon cancer can pose diagnostic challenges. A primary colon carcinoma can metastasize to one or both ovaries, two independent primary tumor...

    Stijn Crobach, Anne M. L. Jansen, Marjolein J. L. Ligtenberg in Familial Cancer (2018)

  19. Article

    Open Access

    Erratum: Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

    Stephanie A Schubert, Dina Ruano, Fadwa A Elsayed, Arnoud Boot in British Journal of Cancer (2018)

  20. Article

    Open Access

    Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

    A substantial fraction of familial colorectal cancer (CRC) and polyposis heritability remains unexplained. This study aimed to identify predisposing loci in patients with these disorders.

    Stephanie A Schubert, Dina Ruano, Fadwa A Elsayed, Arnoud Boot in British Journal of Cancer (2017)

previous disabled Page of 3